MREO vs TWLO · $48.7M cap vs P/E 1087, rev $2.91B
Mereo BioPharma Group PLC ADR (MREO) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
MREO currently screens at market cap $48.7M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the MREO and TWLO stock pages for the full models.
Not investment advice.